Sagimet Biosciences Inc.
SGMTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Sagimet Biosciences Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Sagimet Biosciences Inc. — 10-K filed Mar 12, 2025
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 4 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 2026-03-31 | 952,996 | $4.98M | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 84 | $439 | SEC filing |
| Abacus Planning Group, Inc. | 2026-03-31 | 18,064 | $94.4K | SEC filing |
| Diametric Capital, LP | 2026-03-31 | 10,043 | $52.5K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 27,429 | $143K | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 15,000 | $78.4K | SEC filing |
| China Universal Asset Management Co., Ltd. | 2026-03-31 | 5,501 | $28.7K | SEC filing |
| ACADIAN ASSET MANAGEMENT LLC | 2026-03-31 | 29,636 | Not shown | SEC filing |
| Composition Wealth, LLC | 2026-03-31 | 21,376 | $112K | SEC filing |
| Point72 Asset Management, L.P. | 2026-03-31 | 187,564 | $980K | SEC filing |
| Parallel Advisors, LLC | 2026-03-31 | 849 | $4.44K | SEC filing |
| NFSG Corp | 2026-03-31 | 1,500 | $7.84K | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 68,173 | $356K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 23,066 | $121K | SEC filing |
| MTM Investment Management, LLC | 2026-03-31 | 1,870 | $9.77K | SEC filing |
| HHLR ADVISORS, LTD. | 2026-03-31 | 724,800 | $3.79M | SEC filing |
| Dynamic Technology Lab Private Ltd | 2026-03-31 | 47,820 | $250K | SEC filing |
| FNY Investment Advisers, LLC | 2026-03-31 | 149,761 | Not shown | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 317,550 | $1.66M | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 2,318 | $10.5K | SEC filing |
- Each value is checked against Sagimet Biosciences Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Sagimet Biosciences Inc.'s share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Cresset Asset Management, LLC: 20,079 shares reported 2025-12-31; 20,079 shares reported 2026-03-31.
- FMR LLC: 133 shares reported 2025-12-31; 148 shares reported 2026-03-31.
- CITIGROUP INC: 17,976 shares reported 2025-12-31; 13,586 shares reported 2026-03-31.
- Qube Research & Technologies Ltd: 111,349 shares reported 2025-12-31; 182,738 shares reported 2026-03-31.
- STATE STREET CORP: 117,388 shares reported 2025-12-31; 128,788 shares reported 2026-03-31.
- Blue Owl Capital Holdings LP: 1,243,877 shares reported 2025-12-31; 333,877 shares reported 2026-03-31.
- SIMPLEX TRADING, LLC: 14,227 shares reported 2025-12-31; 13,636 shares reported 2026-03-31.
- Arax Advisory Partners: 115 shares reported 2025-12-31; 115 shares reported 2026-03-31.
- GOLDMAN SACHS GROUP INC: 125,946 shares reported 2025-12-31; 169,259 shares reported 2026-03-31.
- JANE STREET GROUP, LLC: 92,436 shares reported 2025-12-31; 17,187 shares reported 2026-03-31.
- TWO SIGMA INVESTMENTS, LP: 42,532 shares reported 2025-12-31; 40,132 shares reported 2026-03-31.
- MARSHALL WACE, LLP: 780,446 shares reported 2025-12-31; 966,253 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
58 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Sagimet Biosciences Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-20 · Kemble George: Larger than 11 of the 12 other insider sales of Series A Common Stock on file. SEC filing
- 2025-07-21 · Happel David: Larger than all 12 other insider sales of Series A Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-10 | Rozek Elizabeth · Chief Legal & Admin. Officer | Series A Common Stock | S — Open market or private sale | −2,622 | 5.36 | SEC filing |
| 2026-02-10 | Happel David · President & CEO | Series A Common Stock | S — Open market or private sale | −12,101 | 5.36 | SEC filing |
| 2026-02-10 | Martins Eduardo Bruno · Chief Medical Officer | Series A Common Stock | S — Open market or private sale | −3,640 | 5.36 | SEC filing |
| 2026-02-10 | Chauche Thierry · Chief Financial Officer | Series A Common Stock | S — Open market or private sale | −1,312 | 5.36 | SEC filing |
| 2025-11-20 | Kemble George · Executive Chairman | Series A Common Stock | S — Open market or private sale | −37,688 | 7.69 | SEC filing |
| 2025-07-21 | Happel David · President & CEO | Series A Common Stock | S — Open market or private sale | −65,478 | 9.13 | SEC filing |
| 2025-07-21 | Martins Eduardo Bruno · Chief Medical Officer | Series A Common Stock | S — Open market or private sale | −8,277 | 9.13 | SEC filing |
| 2025-07-21 | Rozek Elizabeth · General Counsel and CCO | Series A Common Stock | S — Open market or private sale | −10,780 | 9.13 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-12 | Phillips Anne M. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +39,567 | SEC filing |
| 2026-06-12 | Kemble George · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +39,567 | SEC filing |
| 2026-06-12 | SEIDENBERG BETH C · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +39,567 | SEC filing |
| 2026-06-12 | Hoelscher Paul W. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +39,567 | SEC filing |
| 2026-06-12 | Jarrett Jennifer · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +39,567 | SEC filing |
| 2026-06-12 | GRAMMER ELIZABETH A · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +39,567 | SEC filing |
| 2026-05-28 | Chauche Thierry · Chief Financial Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-05-28 | Happel David · President & CEO | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +300,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-01-29 | NEA 13 GP, Ltd · 10% owner | Series A Common Stock | J — Other acquisition or disposition | −260,950 | SEC filing |
| 2024-01-29 | BASKETT FOREST · 10% owner | Series A Common Stock | J — Other acquisition or disposition | −260,950 | SEC filing |
| 2024-01-29 | SANDELL SCOTT D · 10% owner | Series A Common Stock | J — Other acquisition or disposition | +6,997 | SEC filing |
| 2024-01-29 | BASKETT FOREST · 10% owner | Series A Common Stock | J — Other acquisition or disposition | +11,300 | SEC filing |
| 2024-01-29 | NEA 13 GP, Ltd · 10% owner | Series A Common Stock | J — Other acquisition or disposition | −850,000 | SEC filing |
| 2024-01-29 | SANDELL SCOTT D · 10% owner | Series A Common Stock | J — Other acquisition or disposition | −850,000 | SEC filing |
| 2024-01-29 | BASKETT FOREST · 10% owner | Series A Common Stock | J — Other acquisition or disposition | −850,000 | SEC filing |
| 2024-01-29 | KERINS PATRICK J · 10% owner | Series A Common Stock | J — Other acquisition or disposition | +260,950 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.